These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11033467)

  • 1. [Mycobacterium ulcerans infection].
    Dega H; Chosidow O; Barete S; Carbonnelle B; Grosset J; Jarlier V
    Ann Med Interne (Paris); 2000 Sep; 151(5):339-44. PubMed ID: 11033467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycobacterium ulcerans cutaneous infections: Buruli ulcers].
    Josse R; Guedenon A; Darie H; Anagonou S; Portaels F; Meyers WM
    Med Trop (Mars); 1995; 55(4):363-73. PubMed ID: 8830223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
    Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM
    Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast].
    van der Graaf WT; Scherpbier RW; van der Werf TS
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):312-6. PubMed ID: 10221089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone.
    Marsollier L; Aubry J; Coutanceau E; André JP; Small PL; Milon G; Legras P; Guadagnini S; Carbonnelle B; Cole ST
    Cell Microbiol; 2005 Jul; 7(7):935-43. PubMed ID: 15953026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycobacterium ulcerans infection: epidemiological, clinical and therapeutical aspects].
    Darie H
    Bull Soc Pathol Exot; 2003 Jan; 96(5):368-71. PubMed ID: 15015841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
    Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
    J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Buruli ulcer--Africa's latest mycobacterial scourge].
    Roupe G
    Lakartidningen; 2003 Nov; 100(45):3596-7. PubMed ID: 14650033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Facial localizations of Buruli ulcers: two cases].
    Ouattara D; Aka GK; Meningaud JP; Sica A; Kaba L; Gadegbeku S
    Rev Stomatol Chir Maxillofac; 2003 Sep; 104(4):231-4. PubMed ID: 14631235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-surgical assessment of excised tissue from patients with Buruli ulcer disease: progression of infection in macroscopically healthy tissue.
    Bretzel G; Siegmund V; Racz P; van Vloten F; Ngos F; Thompson W; Biason P; Adjei O; Fleischer B; Nitschke J
    Trop Med Int Health; 2005 Nov; 10(11):1199-206. PubMed ID: 16262747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium ulcerans infection.
    van der Werf TS; van der Graaf WT; Tappero JW; Asiedu K
    Lancet; 1999 Sep; 354(9183):1013-8. PubMed ID: 10501380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantification of mycobacterial DNA.
    Rondini S; Horsfield C; Mensah-Quainoo E; Junghanss T; Lucas S; Pluschke G
    J Pathol; 2006 Jan; 208(1):119-28. PubMed ID: 16261539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for vaccine development against Buruli disease.
    Huygen K
    Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
    Raghunathan PL; Whitney EA; Asamoa K; Stienstra Y; Taylor TH; Amofah GK; Ofori-Adjei D; Dobos K; Guarner J; Martin S; Pathak S; Klutse E; Etuaful S; van der Graaf WT; van der Werf TS; King CH; Tappero JW; Ashford DA
    Clin Infect Dis; 2005 May; 40(10):1445-53. PubMed ID: 15844067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
    Nakanaga K; Saito H; Ishii N; Goto M
    Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.
    Coutanceau E; Marsollier L; Brosch R; Perret E; Goossens P; Tanguy M; Cole ST; Small PL; Demangel C
    Cell Microbiol; 2005 Aug; 7(8):1187-96. PubMed ID: 16008585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium ulcerans ulcers: a proposed surgical management algorithm.
    Chin-Lenn L; Ying D; Leong J; Ross D; Wu T; Nazaretian S; Donahoe S; Silfen R
    Ann Plast Surg; 2006 Jul; 57(1):65-9. PubMed ID: 16799311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.